RJA
JEMD

Raymond James & Associates’s Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share JEMD Stock Holding History

Raymond James & Associates’s Portfolio JEMD Stock Details JEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,724
Closed -$75K – 4129
2022
Q3 		$75K Sell
11,724
-669
-5% -$4.38K ﹤0.01% 3657
2022
Q2 		$83K Buy
12,393
+56
+0.5% +$387 ﹤0.01% 3718
2022
Q1 		$86K Sell
12,337
-7,738
-39% -$56.2K ﹤0.01% 3854
2021
Q4 		$152K Buy
20,075
+2,667
+15% +$20.7K ﹤0.01% 3774
2021
Q3 		$139K Buy
17,408
+1,211
+7% +$9.8K ﹤0.01% 3765
2021
Q2 		$132K Sell
16,197
-267
-2% -$2.17K ﹤0.01% 3787
2021
Q1 		$130K Sell
16,464
-7,637
-32% -$59.5K ﹤0.01% 3730
2020
Q4 		$180K Sell
24,101
-61,503
-72% -$452K ﹤0.01% 3437
2020
Q3 		$658K Sell
85,604
-7,413
-8% -$55.2K ﹤0.01% 2448
2020
Q2 		$666K Buy
93,017
+33,419
+56% +$219K ﹤0.01% 2417
2020
Q1 		$369K Buy
59,598
+7,705
+15% +$64.9K ﹤0.01% 2641
2019
Q4 		$462K Buy
51,893
+12,666
+32% +$112K ﹤0.01% 2788
2019
Q3 		$341K Buy
39,227
+10,409
+36% +$93.1K ﹤0.01% 2933
2019
Q2 		$256K Buy
28,818
+13,873
+93% +$121K ﹤0.01% 3100
2019
Q1 		$130K Buy
14,945
+4,195
+39% +$35.3K ﹤0.01% 3340
2018
Q4 		$82K Buy
+10,750
New +$83.2K ﹤0.01% 3333

Raymond James & Associates's JEMD Position: Q4 2022 in Review

Raymond James & Associates sold out of Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share (JEMD) in Q4 2022, closing a stake of 11,724 shares — an estimated $75K sold.

Raymond James & Associates first reported a position in JEMD in Q4 2018 and held it in 16 quarters. The position peaked at $666K in Q2 2020. 0 funds tracked by Wall St. Rank hold JEMD as of Q4 2022.

  • Raymond James & Associates reported no remaining Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 11,724 Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share shares in Q4 2022, an estimated $75K.
  • Raymond James & Associates first reported a position in Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share in Q4 2018 and held it in 16 quarters.
  • Raymond James & Associates's Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share position peaked at $666K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.